Cargando…
Nanocarriers Call the Last Shot in the Treatment of Brain Cancers
Our brain is protected by physio-biological barriers. The blood–brain barrier (BBB) main mechanism of protection relates to the abundance of tight junctions (TJs) and efflux pumps. Although BBB is crucial for healthy brain protection against toxins, it also leads to failure in a devastating disease...
Autores principales: | Mehrabian, Amin, Mashreghi, Mohammad, Dadpour, Saba, Badiee, Ali, Arabi, Leila, Hoda Alavizadeh, Seyedeh, Alia Moosavian, Seyedeh, Reza Jaafari, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905056/ https://www.ncbi.nlm.nih.gov/pubmed/35253549 http://dx.doi.org/10.1177/15330338221080974 |
Ejemplares similares
-
Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach
por: Mehrabian, Amin, et al.
Publicado: (2022) -
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
por: Mehrabian, Amin, et al.
Publicado: (2023) -
Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy
por: Mirhadi, Elaheh, et al.
Publicado: (2022) -
Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023) -
Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
por: Mashreghi, Mohammad, et al.
Publicado: (2020)